Linden, Joel

International Union of Pharmacology. XXV. Nomenclature and Classification of Adenosine Receptors

Fredholm, B. B., IJzerman, A. P., Jacobson, K. A., Klotz, K.-N., & Linden, J. (2001) · Pharmacological Reviews

Adenosine and Purinergic SignalingReceptor Mechanisms and Signaling

Cited by 2,585

Purinergic regulation of the immune system

Cekic, C., & Linden, J. (2016) · Nature Reviews Immunology

Adenosine and Purinergic SignalingBiochemical and Molecular Research

Cited by 787

The cholesterol transporter ABCG1 links cholesterol homeostasis and tumour immunity

Sag, D., Cekic, C., Wu, R., Linden, J., & Hedrick, C. C. (2015) · Nature Communications

Immune cells in cancerCancer, Lipids, and Metabolism

Cited by 205

P-Selectin–Mediated Platelet-Neutrophil Aggregate Formation Activates Neutrophils in Mouse and Human Sickle Cell Disease

Polanowska-Grabowska, R., Wallace, K., Field, J. J., Chen, L., Marshall, M. A., Figler, R., Gear, A. R. L., & Linden, J. (2010) · Arteriosclerosis, Thrombosis, and Vascular Biology

Hemoglobinopathies and Related DisordersPlatelet Disorders and Treatments

Cited by 189

Adenosine-Induced Vasoconstriction In Vivo: Role of the Mast Cell and A3Adenosine Receptor

Shepherd, R. K., Linden, J., & Duling, B. R. (1996) · Circulation Research

Adenosine and Purinergic SignalingMast cells and histamine

Cited by 97

The Role of Fibrocytes in Sickle Cell Lung Disease

Field, J. J., Burdick, M. D., DeBaun, M. R., Strieter, B. A., Liu, L., Mehrad, B., Rose, C. E., Linden, J., & Strieter, R. M. (2012) · PLoS ONE

Hemoglobinopathies and Related DisordersInterstitial Lung Diseases and Idiopathic Pulmonary Fibrosis

Cited by 23